<?xml version="1.0" encoding="UTF-8"?>
<records>
<record>
<language>eng</language>
<publisher>Excellent Publishers</publisher>
<journalTitle>International Journal of Current Microbiology and Applied Sciences (IJCMAS) CODEN(USA)-IJCMO9</journalTitle>
<issn>2319-7692</issn>
<eissn>2319-7706</eissn>
<publicationDate>2015-12-20</publicationDate>
<volume>4</volume>
<issue>12</issue>
<startPage>36</startPage>
<endPage>41</endPage>
<documentType>article</documentType>



<title language="eng">
Seroprevalence of Cytomegalovirus among Blood Donors</title>
<authors>
			<author>
			<name>G. Velvizhi</name>
			<affiliationId>1</affiliationId>
			</author>
			<author>
			<name>R. Vaithegi</name>
			<affiliationId>2</affiliationId>
			</author>
			<author>
			<name>G. Sucilathangam</name>
			<affiliationId>3</affiliationId>
			</author>
			<author>
			<name>C. Revathy</name>
			<affiliationId>4</affiliationId>
			</author>
			
			
</authors>

<affiliationsList>
			<affiliationName affiliationId="1">
			Department of Microbiology, Tirunelveli Medical College, Tirunelveli - 627 011
			</affiliationName>
			
			
					
</affiliationsList>
<abstract language="eng">
			<p>Human Cytomegalovirus (CMV) is one of the most significant pathogens infecting
immunosuppressed individuals. CMV is known to be a significant cause of
morbidity and mortality following blood transfusion in immunocompromised
individuals. The immunosuppressed population for whom CMV free blood
products are requested is increasing due to advances in medical care. The most
effective way to minimize the risk of CMV transmission in high risk recipients
would be to administer CMV free blood products. The study was performed to find
out the seroprevalence of Human CMV among voluntary blood donors in
Tirunelveli.A total of 92 voluntary blood donors were tested for IgM and IgG anti-
CMV antibodies by ELISA technique .Demographic details and laboratory results
were analyzed. Among the 92 donors, 82 (89%) were males and 10 (11%) were
females. It was found that 7 (7.6%) donors were positive for IgM and 76 (82.6%)
donors were positive for IgG.Human CMV is highly prevalent and is a threat to the
safety of blood transfusion. Hence it would be useful to screen blood donors for
CMV to identify the CMV seronegative donors to maintain an inventory and use
them as donors for immune compromised patients .Other preventive strategies like
leukoreduction or pathogen inactivation can be made available to prevent CMV
transmission.</p>
</abstract>

<fullTextUrl format="pdf">
http://ijcmas.com/vol-4-12/G. Velvizhi, et al.pdf
</fullTextUrl>

<keywords language="eng">
		<keyword>Cytomegalo
Virus</keyword>
</keywords>
<keywords language="eng">
		<keyword>Blood Donors</keyword>
</keywords>
<keywords language="eng">
		<keyword>IgM and IgG
Anti-CMV
Antibodies
ELISA</keyword>
</keywords>
<keywords language="eng">
		<keyword>Immunosuppressed
Individuals</keyword>
</keywords>


</record>
</records>